Loading company…
Surio Therapeutics develops cancer targeting and drug delivery technology.
Founded in 2019 and based in Suzhou, China, Surio Therapeutics develops cancer targeting technology and drug delivery systems. Its ATTACK platform uses small molecules to place artificial antigens on cancer cell surfaces and can support delivery of different therapies and diagnostic probes.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in